FDA Marketing Rules Stretch To Drugmakers' Media Pitches

Law360, New York (November 13, 2012, 10:21 PM EST) -- The U.S. Food and Drug Administration recently scolded Cornerstone Therapeutics Inc. for failing to include information about a drug's risks in a letter seeking publicity from media outlets, an unusual warning that shows the agency considers all promotional materials, not just those directed to the public, to be under its purview.

In a letter dated Oct. 31, the FDA's Office of Prescription Drug Promotion told Cornerstone that a pitch letter and press release sent out by the company's public relations firm were false and misleading. The...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.